Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 501 through 510 of 961 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals

Bell, John C | Ottawa Hospital Research Institute | Operating Grant | $50,000

CIHR Ontario 2021

Identification of microbial factors to modulate immune dysregulation and treat post-COVID-19 syndrome.

Falcone, Emilia L | Institut de recherches cliniques de Montréal | Operating Grant | $493,955

CIHR Quebec 2021

COVID-19 Variant Supplement – Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19

Xing, Zhou | McMaster University | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Mitigation strategies against the public transmission of airborne COVID‑19 in high occupancy structures: a program of research to develop optimized mechanical ventilation systems

Zhong, Lexuan | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

Developing wise practices for a culturally safe rapid public health response to COVID‑19 with Pikwàkanagàn First Nation

Gifford, Wendy A | University of Ottawa | Other | $200,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID‑19 through mechanism-based drug repurposing and combinatorial organoid screening.

Cherkasov, Artem | University of British Columbia | Operating Grant | $60,000

CIHR British Columbia 2021

Exploring Rehabilitation Needs and Access to Services for Long COVID

Gross, Douglas P | University of Alberta | Operating Grant | $152,778

CIHR Alberta 2021

COVID-19 and Precarious Employment (COPE)

O'Campo, Patricia J | Unity Health Toronto | Project Grant | $302,175

CIHR Ontario 2021

COVID-19 Variant Network – Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

Houghton, Michael | University of Alberta | Operating Grant | $100,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Development of a novel DC-targeting vaccine that targets COVID‑19 spike protein to control COVID‑19 infection

Yao, Xiao-Jian | University of Manitoba | Operating Grant | $50,000

CIHR Manitoba 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals

Identification of microbial factors to modulate immune dysregulation and treat post-COVID-19 syndrome.

COVID-19 Variant Supplement – Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19

COVID-19 Variant Supplement – Mitigation strategies against the public transmission of airborne COVID‑19 in high occupancy structures: a program of research to develop optimized mechanical ventilation systems

Developing wise practices for a culturally safe rapid public health response to COVID‑19 with Pikwàkanagàn First Nation

COVID-19 Variant Supplement – Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID‑19 through mechanism-based drug repurposing and combinatorial organoid screening.

Exploring Rehabilitation Needs and Access to Services for Long COVID

COVID-19 and Precarious Employment (COPE)

COVID-19 Variant Network – Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

COVID-19 Variant Supplement – Development of a novel DC-targeting vaccine that targets COVID‑19 spike protein to control COVID‑19 infection